Table 1.
PPA‐AD participant # | PPA sub‐type | Sex | Education (years) | Age at onset (years) | Age at scan (years) | Age at death (years) | Symptom duration (years) | Scan/death interval (years) | Postmortem interval (hours) | Fixative | APOE status |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | L | Male | 16 | 56 | 61 | 62 | 4.7 | 0.6 | 6 | F | 3,3 |
2 | U | Male | 12 | 55 | 61 | 64 | 7.9 | 2.1 | 14 | F | 3,3 |
3 | L | Male | 15 | 67 | 73 | 76 | 8.6 | 2.0 | 8 | P | 3,4 |
4 | U | Male | 14 | 51 | 58 | 61 | 9.4 | 2.5 | 19 | P | 3,4 |
5 | G | Male | 18 | 72 | 75 | 78 | 6.2 | 2.5 | 28 | P | 3,4 |
Ages were calculated from date of birth to event (i.e., disease onset, scan, or death) and were rounded for summary purposes.
Abbreviations: APOE = apolipoprotein E; F = formalin; G = agrammatic; L = logopenic; P = paraformaldehyde; U = unclassifiable due to severity of impairments.